Methylmalonic acid values in healthy Dutch children

Marije Hogeveen1, Ingrid van Beynum, Arno van Rooij

  • 1Dept. of Paediatrics, Metabolic and Endocrine Diseases, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. m.hogeveen@cukz.umcn.nl

Abstract

Insights

Plasma methylmalonic acid (MMA) levels in Dutch children are primarily determined by cobalamin (Cbl) levels. This association strengthens with age, highlighting Cbl

Area of Science:

  • Biochemistry
  • Pediatric Nutrition
  • Clinical Chemistry

Background:

  • Plasma methylmalonic acid (MMA) is a specific biomarker for functional cobalamin (Cbl) deficiency.
  • Cobalamin deficiency in children can lead to severe, non-specific symptoms including developmental delay, seizures, and failure to thrive, potentially causing irreversible neurological damage.

Purpose of the Study:

  • To analyze plasma MMA concentrations in a cohort of Dutch children.
  • To identify and evaluate factors influencing plasma MMA concentrations in pediatric populations.

Main Methods:

  • Cross-sectional analysis of 186 Dutch children aged 0-19 years.
  • Measurement of plasma MMA, total homocysteine (tHcy), cobalamin (Cbl), and serum creatinine.
  • Collection of data on medical history, age, and sex.

Main Results:

  • The geometric mean plasma MMA concentration was 0.17 micromol/l.
  • Plasma MMA concentrations were significantly higher in children with low cobalamin levels.
  • Cobalamin (Cbl) was identified as the strongest determinant of plasma MMA, with the association strengthening with increasing age.

Conclusions:

  • Plasma cobalamin (Cbl) is the primary determinant of plasma MMA in Dutch children.
  • The relationship between MMA and Cbl becomes more pronounced as children age.